US has given its approval to novel COVID-19 antibody medication for high-risk patients

Officials in the United States have approved a new COVID-19 antibody medication for persons with major health issues or allergies who are unable to receive appropriate protection via immunisation.

The Food and Medication Administration authorised AstraZeneca’s drug combination emergency use on Wednesday.

Cancer patients, organ transplant recipients, and persons with severe vaccine allergies may benefit from the medicine. According to health professionals, around 2% to 3% of the US population falls into this category.

Other antibody medications are used to treat COVID-19 infection or to prevent infection following probable viral exposure. The new AstraZeneca medicine is meant to be used as a long-term preventative measure rather than a therapy.

 

Medically Speaking

Recent Posts

Dysautonomia: The Silent Illness Affecting Millions Globally

Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…

2 days ago

Chyawanprash: Your Ayurvedic Shield Against Cough & Cold

https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…

2 days ago

Why Winter Morning Walks (7-9 AM) Are Perfect for Your Health

Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…

2 days ago

Does Maida Stick to Your Gut? Debunking Myths and Health Risks

Does Maida Stick To Your Gut Lining: In this article, we debunk the common myth…

2 days ago

Think Twice Before Heating Packaged Milk: Hidden Risks You Should Know!

https://youtu.be/4NTKSfNf1TM?si=Y4xkEOKDUvqpIEZt The Disadvantages of Heating Packaged Milk Milk is a staple in many households and…

2 days ago

MENTAL HEALTH STRUGGLES: THE LONG-TERN IMPACT ON TEENAGERS

A recent study has revealed a growing mental health crisis among teenagers globally, with nearly…

3 days ago